Journal Article

Many reports on adverse effects related to positive gastrointestinal (GI) contrast media (CM) predate 2000; therefore, a literature review on their current safety profile was warranted. This article reviews the literature and updates the Contrast Media Safety Committee guidelines of the European Society of Urogenital Radiology on the safety of positive GI iodine-based and barium sulphate-based CM. [...]

As complex individualized behaviors in mice arise even when genes and environment are held constant, emerging social group structures should also depend on individual behavior. Adult hippocampal neurogenesis drives individual behavior and is involved in certain social behaviors. [...]

Sleep is essential for synaptic homeostasis, a proposed mechanism whereby wakefulness leads to synaptic potentiation and sleep facilitates synaptic down-selection. Synaptic vesicle glycoprotein 2A (SV2A), whose availability is quantifiable by [¹⁸F]SynVesT-1 positron emission tomography (PET), is commonly interpreted as a proxy for synaptic density. [...]

Friedreich's ataxia (FA) is a rare, autosomal recessive neurodegenerative disease that primarily affects children and adolescents in their transition to adulthood, which is associated with several adverse life events caused by the disease progression. This article aims to describe life events associated with FA and their impact on patient-reported outcomes in pediatric and adult onsets. [...]

Ischemic stroke remains a leading cause of disability and mortality worldwide, with limited acute therapeutic options. Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates endothelial function, vascular integrity, and immune responses, and reduced circulating S1P levels have been reported in ischemic stroke. [...]

Hemispherotomy is a surgical intervention for severe drug-resistant epilepsy that fully disconnects the lesional brain hemisphere from the rest of the nervous system. This creates a rare opportunity to explore whether consciousness can be sustained without external input. [...]

The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of tau regulation, degradation, and propagation; advances in biomarker development for the diagnosis and staging of tauopathies; and evolving therapeutic strategies targeting diverse aspects of tau pathophysiology. [...]

Disruption of circadian rhythms is a key feature of neurodegenerative diseases and a non-motor feature of Parkinson's disease, which significantly impairs health-related quality of life; yet, the underlying mechanisms are only partially understood. Preclinical animal models with neuropathological and symptomatic significance might contribute to a better understanding of circadian dysfunction. [...]

Parkinson's disease (PD) is characterized by marked phenotypic heterogeneity particularly with regard to cognitive decline, which may be partly driven by ageing-related molecular pathways. Peroxisome Proliferator-Activated Receptor γ (PPARγ) represents a key downstream component of such pathways, while genetic variation in its coactivator gene peroxisome proliferator-activated receptor γ coactivator-1-α (PPARGC1A) may further modulate disease trajectories. [...]

Psychiatric biomarker research is characterized by subtle but potentially informative biological signals that often lie close to methodological noise. Compared with neurodegenerative or infectious diseases, candidate blood and cerebrospinal fluid (CSF) markers in major psychiatric disorders often show small-to-moderate group differences, substantial patient-control overlap, and a more demanding path to clinical use. [...]